Parliamentary activity

Answering body: Department of Health and Social Care

It is crucial we protect the safety of haemophilia care and the Government is committed to implementing recommendation 9 of the 2024 Infected Blood Inquiry report.

The Government is committed to improving the lives of those living with rare diseases, such as haemophilia. The UK Rare Diseases Framework sets out four priorities collaboratively developed with the rare disease community: these include getting a final diagnosis faster; increasing awareness of rare diseases among healthcare professionals; better coordination of care; and improving access to specialist care, treatments, and drugs. We published the fifth annual England action plan in February 2026, where we report on the steps we have taken to advance these priorities.

This includes peer review of UK comprehensive care centres, which has been an essential part of haemophilia services for many years. The triennial audit was replaced in 2019 with a more formal peer review process on a five-year cycle.

The final peer review report is expected to be published imminently and once published, will be shared with the NHSE Specialised Commissioning Quality Oversight Group for consideration and action. This will be supported by a letter to Integrated Care Boards and Trust Boards, emphasising the valuable role of peer review and ask for confirmation of their commitment to review and implement the peer review findings.

The Haemophilia Service Specification has been updated by the Blood Disorders Clinical Reference Group and is making its way through final approvals, having undergone public consultation. The new specification includes a contractual requirement for providers to participate in, and act upon peer review findings.

Answering body: Department of Health and Social Care

It is crucial we protect the safety of haemophilia care, and the Government is committed to implementing recommendation 9 of the 2024 Infected Blood Inquiry report.

The Government is committed to improving the lives of those living with rare diseases, such as haemophilia. The UK Rare Diseases Framework sets out four priorities collaboratively developed with the rare disease community: these include getting a final diagnosis faster; increasing awareness of rare diseases among healthcare professionals; better coordination of care; and improving access to specialist care, treatments, and drugs. We published the fifth annual England action plan in February 2026, where we report on the steps we have taken to advance these priorities.

In relation to recommendation 9, a to c, of the Infected Blood Inquiry, peer review of United Kingdom comprehensive care centres has been an essential part of haemophilia services for many years. The triennial audit was replaced in 2019 with a more formal peer review process on a five-year cycle.

The final peer review report is expected to be published imminently and once published, it will be shared with the NHS England Specialised Commissioning Quality Oversight Group for consideration and action. This will be supported by a letter to integrated care boards and trust boards, emphasising the valuable role of peer review and asking for confirmation of their commitment to review and implement the peer review findings.

The Haemophilia Service Specification has been updated by the Blood Disorders Clinical Reference Group and is making its way through final approvals, having undergone public consultation. The new specification includes a contractual requirement for providers to participate in and act upon peer review findings.

Regarding 9d, the Clinical Community and the NHS England Clinical Reference Group for Blood Disorders supports the need to develop and strengthen multi-disciplinary networks. NHS England has drafted a proposed National Clinical Network Specification specifically for these networks, which is dependent on additional funding, and which would embed key new requirements for providers to participate in a networked model of care.

In response to 9e, all diseases or conditions where a non-plasma treatment exists to replace a plasma/blood-derived treatment are now addressed by commissioning policies or funding agreements. There are some specific regimens which are subject to ongoing clinical policy development but in each case there are alternative regimens or treatment approaches which negate the use of plasma-derived medicines.

Of particular interest to the clinical and patient community is the development of a clinical commissioning policy for recombinant Von Willebrand factor, which is currently licensed for prophylaxis in adults, as regular treatment for those with the severest bleeding, but which is not currently commissioned for this indication. Funding will be required to implement this clinical policy for all ages, and this has not yet been identified.

Finally, for 9f, NHS England currently provides ‘central’ funding of approximately 40% of the total annual cost for running the National Haemophilia Database. A task and finish group relating to the database has been established, reporting into the overarching recommendation 9 expert group.

As of February 2026, stakeholders involved in the recommendation 9f working group are in agreement that the registry has been and remains immensely valuable in supporting the provision of clinical care. NHS England continues to work with the United Kingdom Haemophilia Centres Doctors' Organisation to understand the requirement for increased funding.

Further progress on implementing recommendation 9 is subject to additional funding, and this has not yet been identified. NHS England and the Department will continue to work together to provide progress updates on the Government Reporting Integration Platform.

Answering body: Cabinet Office

On 30 October, the Government launched a public consultation on proposed changes to the infected blood compensation scheme. The core purpose of this consultation was to gather views on how the Government intends to implement the Infected Blood Inquiry’s recommendations, and responses from the infected blood community were particularly encouraged.

Every response to this consultation is being considered carefully and with the seriousness the issue deserves. The consultation closed on 22 January, and the Government will publish its response within 12 weeks of this closing date.

Answering body: Department of Health and Social Care

Medical research was an important area examined in the inquiry, with it concluding that ‘the value of such research to society is enhanced rather than undermined by undertaking research in an ethical and moral way’.

The Department funds research on health and social care through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health and care.

In January 2026, the NIHR published the attached report, From subject to participant and partner, on its website, summarising the concerns raised in the inquiry report, as well as a summary of the research governance changes since and a synthesis of an in-person workshop. The NIHR and partners who attended the workshop are committed to upholding the highest standards of research governance to drive better inclusivity in the evidence base for care, working with those who use, manage, or work in health and care services to share learning and drive improvement. The NIHR requires all applicants to demonstrate how their research will address existing inequalities in health and social care as a condition of funding.

The NIHR was created in 2006, many decades after individuals received infected blood in the United Kingdom. The NIHR did not therefore fund any clinical trials or research where individuals received infected blood. The NIHR has strong ethical, safety, and legal governance arrangements, including processes to ensure informed consent for those participating in research, and includes parental and guardian consent for children involved in research.

The NIHR funds a wide range of research relevant to the Infected Blood Inquiry. Work includes making blood donation and transfusion safer by improving transfusion practice, reducing variation in practice and ensuring greater resilience and efficiency throughout the blood supply chain.

This includes research on improving the safety of blood transfusions and blood products, and research to improve better detection and treatments for blood borne infections, including through opt out testing in accident and emergency departments for HIV, and Hepatitis B and C.

Answering body: Department of Health and Social Care

Given the long-running nature of the infected blood scandal, not all medical records will still be available, and eligibility for compensation will be determined based on the balance of probabilities.

The Infected Blood Compensation Authority (IBCA) will try to get as much information, including medical records and information about an applicant’s condition, from organisations who already have this information. This should mean those claiming will be asked for the least amount of information possible.

The IBCA will provide assistance to those who believe their medical records have been lost or destroyed. The role of the IBCA’s claim managers includes helping individuals who are claiming to gather information, including medical evidence where available, to support their claim.

In July 2025, the Permanent Secretary of the Cabinet Office wrote to the chairs of the Public Accounts and Public Administration and Constitutional Affairs Committees to set out the measures being taken to prioritise faster payments to victims of the infected blood scandal. One of these measures is to use the powers in the Victims and Prisoners Act to get records from the Infected Blood Inquiry, and using testimony to contribute to the assessment of proof of infection.

Organisations that remove, store, and use human tissue for some types of health research, medical treatment, post-mortem examination, education and training, and for display in public, are independently regulated by the Human Tissue Authority.

Answering body: Cabinet Office

Compensation tariffs for infected and affected people under the Scheme have been informed, but not limited, by current practice in UK courts and tribunals.

The Infected Blood Inquiry Response Expert Group Final Report provides detail on how the Fatal Accidents Act 1976 was considered when developing the tariffs under the Scheme. This can be found here: https://www.gov.uk/government/publications/infected-blood-inquiry-response-expert-group-summary-report/infected-blood-inquiry-response-expert-group-final-report#foreword-by-the-minister-for-the-cabinet-office.

Answering body: Cabinet Office

In line with recommendations of the Infected Blood Inquiry, the Government has publicly consulted on proposed changes to the compensation scheme. The consultation closed on 22nd January, and we will publish our response within 12 weeks of the consultation’s closing date. The Government is keen to prioritise amendments to the compensation scheme as recommended, while continuing to focus on the swift delivery of compensation to all victims of this scandal.

Answering body: Cabinet Office

The Government launched a public consultation on proposed changes to the infected blood compensation scheme on 30 October 2025 that ran for the standard 12 weeks and closed on 22 January. This consultation adhered to the Cabinet Office Consultation Principles and was open to the public, with responses particularly encouraged from those in the infected blood community. The Government is considering each response to the consultation with the seriousness the issue deserves, and will publish its response within 12 weeks of the consultation’s closing date. An Equality Impact Assessment is not required to be carried out for public consultations, but the Government will provide one alongside any legislation arising from the implementation of the consultation’s outcome.

In its Additional Report, the Inquiry recommended that the Government reconsider how the Infected Blood Compensation Scheme provides compensation to those currently receiving Special Category Mechanism (SCM) payments or its equivalents. The Government accepted this recommendation.

The public consultation proposed that anyone currently receiving SCM or equivalent payments through the Infected Blood Support Schemes would be automatically eligible for a Severe Health Condition award. The Government has also consulted on how eligibility should be established for people who are not registered with an Infected Blood Support Scheme (IBSS) but who experience the same impact on their day-to-day life for the same reasons.

The Technical Expert Group (TEG) is convening a series of roundtables with key organisations and charity representatives to discuss aspects of the Infected Blood Inquiry Additional Report recommendations for the compensation scheme, to inform their advice to the Government. This targeted engagement is separate to the Government’s consultation. The TEG held roundtables on 15 and 17 December 2025, which focused on establishing the eligibility criteria for living infected people who are not currently registered with an IBSS, in relation to the award to recognise impacts associated with SCM, and its equivalents. The attendee list was informed by the key representatives in the infected blood community that the Government regularly engages with. To ensure transparency, the minutes of meetings of the TEG are published on GOV.UK. The minutes of these roundtable meetings were published on 29 January 2026.

The TEG invited further written responses from the representatives to supplement the discussion of the roundtables. The TEG therefore received written responses after the initial roundtables on SCM had been held. The TEG have, since then, reviewed these written responses and will be making sure they too are properly reflected in a summary document which will be published on GOV.UK.

Answering body: Cabinet Office

The Government launched a public consultation on proposed changes to the infected blood compensation scheme on 30 October 2025 that ran for the standard 12 weeks and closed on 22 January. This consultation adhered to the Cabinet Office Consultation Principles and was open to the public, with responses particularly encouraged from those in the infected blood community. The Government is considering each response to the consultation with the seriousness the issue deserves, and will publish its response within 12 weeks of the consultation’s closing date. An Equality Impact Assessment is not required to be carried out for public consultations, but the Government will provide one alongside any legislation arising from the implementation of the consultation’s outcome.

In its Additional Report, the Inquiry recommended that the Government reconsider how the Infected Blood Compensation Scheme provides compensation to those currently receiving Special Category Mechanism (SCM) payments or its equivalents. The Government accepted this recommendation.

The public consultation proposed that anyone currently receiving SCM or equivalent payments through the Infected Blood Support Schemes would be automatically eligible for a Severe Health Condition award. The Government has also consulted on how eligibility should be established for people who are not registered with an Infected Blood Support Scheme (IBSS) but who experience the same impact on their day-to-day life for the same reasons.

The Technical Expert Group (TEG) is convening a series of roundtables with key organisations and charity representatives to discuss aspects of the Infected Blood Inquiry Additional Report recommendations for the compensation scheme, to inform their advice to the Government. This targeted engagement is separate to the Government’s consultation. The TEG held roundtables on 15 and 17 December 2025, which focused on establishing the eligibility criteria for living infected people who are not currently registered with an IBSS, in relation to the award to recognise impacts associated with SCM, and its equivalents. The attendee list was informed by the key representatives in the infected blood community that the Government regularly engages with. To ensure transparency, the minutes of meetings of the TEG are published on GOV.UK. The minutes of these roundtable meetings were published on 29 January 2026.

The TEG invited further written responses from the representatives to supplement the discussion of the roundtables. The TEG therefore received written responses after the initial roundtables on SCM had been held. The TEG have, since then, reviewed these written responses and will be making sure they too are properly reflected in a summary document which will be published on GOV.UK.

Answering body: Cabinet Office

The Government launched a public consultation on proposed changes to the infected blood compensation scheme on 30 October 2025 that ran for the standard 12 weeks and closed on 22 January. This consultation adhered to the Cabinet Office Consultation Principles and was open to the public, with responses particularly encouraged from those in the infected blood community. The Government is considering each response to the consultation with the seriousness the issue deserves, and will publish its response within 12 weeks of the consultation’s closing date. An Equality Impact Assessment is not required to be carried out for public consultations, but the Government will provide one alongside any legislation arising from the implementation of the consultation’s outcome.

In its Additional Report, the Inquiry recommended that the Government reconsider how the Infected Blood Compensation Scheme provides compensation to those currently receiving Special Category Mechanism (SCM) payments or its equivalents. The Government accepted this recommendation.

The public consultation proposed that anyone currently receiving SCM or equivalent payments through the Infected Blood Support Schemes would be automatically eligible for a Severe Health Condition award. The Government has also consulted on how eligibility should be established for people who are not registered with an Infected Blood Support Scheme (IBSS) but who experience the same impact on their day-to-day life for the same reasons.

The Technical Expert Group (TEG) is convening a series of roundtables with key organisations and charity representatives to discuss aspects of the Infected Blood Inquiry Additional Report recommendations for the compensation scheme, to inform their advice to the Government. This targeted engagement is separate to the Government’s consultation. The TEG held roundtables on 15 and 17 December 2025, which focused on establishing the eligibility criteria for living infected people who are not currently registered with an IBSS, in relation to the award to recognise impacts associated with SCM, and its equivalents. The attendee list was informed by the key representatives in the infected blood community that the Government regularly engages with. To ensure transparency, the minutes of meetings of the TEG are published on GOV.UK. The minutes of these roundtable meetings were published on 29 January 2026.

The TEG invited further written responses from the representatives to supplement the discussion of the roundtables. The TEG therefore received written responses after the initial roundtables on SCM had been held. The TEG have, since then, reviewed these written responses and will be making sure they too are properly reflected in a summary document which will be published on GOV.UK.

Answering body: Cabinet Office

Given the historic nature of the infected blood scandal, the Government recognises that not all medical records will still be available. The Infected Blood Compensation Scheme has been designed to minimise as far as possible the burden on those applying, and as set out in the Infected Blood Compensation Scheme Regulations 2024, eligibility for the Infected Blood Compensation Scheme will be determined based on the balance of probabilities. The Infected Blood Compensation Authority will provide assistance to those who believe their medical records have been lost or destroyed.

Work has taken place across Government and the Infected Blood Compensation Authority to understand steps that can be taken to reduce as many barriers as possible to support the processing of claims. On 3 July 2025, the Permanent Secretary of the Cabinet Office wrote to the Chairs of the PAC and PACAC Committees to set out the measures being taken to prioritise faster payments to victims of the infected blood scandal. One of these measures is to use the powers in the Victims and Prisoners Act to get records from the Infected Blood Inquiry, and using testimony to contribute to the assessment of proof of infection.

Answering body: Cabinet Office

The Government launched a public consultation on proposed changes to the infected blood compensation scheme on 30 October 2025 that ran for the standard 12 weeks and closed on 22 January. This consultation adhered to the Cabinet Office Consultation Principles and was open to the public, with responses particularly encouraged from those in the infected blood community. The Government is considering each response to the consultation with the seriousness the issue deserves, and will publish its response within 12 weeks of the consultation’s closing date. An Equality Impact Assessment is not required to be carried out for public consultations, but the Government will provide one alongside any legislation arising from the implementation of the consultation’s outcome.

In its Additional Report, the Inquiry recommended that the Government reconsider how the Infected Blood Compensation Scheme provides compensation to those currently receiving Special Category Mechanism (SCM) payments or its equivalents. The Government accepted this recommendation.

The public consultation proposed that anyone currently receiving SCM or equivalent payments through the Infected Blood Support Schemes would be automatically eligible for a Severe Health Condition award. The Government has also consulted on how eligibility should be established for people who are not registered with an Infected Blood Support Scheme (IBSS) but who experience the same impact on their day-to-day life for the same reasons.

The Technical Expert Group (TEG) is convening a series of roundtables with key organisations and charity representatives to discuss aspects of the Infected Blood Inquiry Additional Report recommendations for the compensation scheme, to inform their advice to the Government. This targeted engagement is separate to the Government’s consultation. The TEG held roundtables on 15 and 17 December 2025, which focused on establishing the eligibility criteria for living infected people who are not currently registered with an IBSS, in relation to the award to recognise impacts associated with SCM, and its equivalents. The attendee list was informed by the key representatives in the infected blood community that the Government regularly engages with. To ensure transparency, the minutes of meetings of the TEG are published on GOV.UK. The minutes of these roundtable meetings were published on 29 January 2026.

The TEG invited further written responses from the representatives to supplement the discussion of the roundtables. The TEG therefore received written responses after the initial roundtables on SCM had been held. The TEG have, since then, reviewed these written responses and will be making sure they too are properly reflected in a summary document which will be published on GOV.UK.

Answering body: Cabinet Office

The Government launched a public consultation on proposed changes to the infected blood compensation scheme on 30 October 2025 that ran for the standard 12 weeks and closed on 22 January. This consultation adhered to the Cabinet Office Consultation Principles and was open to the public, with responses particularly encouraged from those in the infected blood community. The Government is considering each response to the consultation with the seriousness the issue deserves, and will publish its response within 12 weeks of the consultation’s closing date. An Equality Impact Assessment is not required to be carried out for public consultations, but the Government will provide one alongside any legislation arising from the implementation of the consultation’s outcome.

In its Additional Report, the Inquiry recommended that the Government reconsider how the Infected Blood Compensation Scheme provides compensation to those currently receiving Special Category Mechanism (SCM) payments or its equivalents. The Government accepted this recommendation.

The public consultation proposed that anyone currently receiving SCM or equivalent payments through the Infected Blood Support Schemes would be automatically eligible for a Severe Health Condition award. The Government has also consulted on how eligibility should be established for people who are not registered with an Infected Blood Support Scheme (IBSS) but who experience the same impact on their day-to-day life for the same reasons.

The Technical Expert Group (TEG) is convening a series of roundtables with key organisations and charity representatives to discuss aspects of the Infected Blood Inquiry Additional Report recommendations for the compensation scheme, to inform their advice to the Government. This targeted engagement is separate to the Government’s consultation. The TEG held roundtables on 15 and 17 December 2025, which focused on establishing the eligibility criteria for living infected people who are not currently registered with an IBSS, in relation to the award to recognise impacts associated with SCM, and its equivalents. The attendee list was informed by the key representatives in the infected blood community that the Government regularly engages with. To ensure transparency, the minutes of meetings of the TEG are published on GOV.UK. The minutes of these roundtable meetings were published on 29 January 2026.

The TEG invited further written responses from the representatives to supplement the discussion of the roundtables. The TEG therefore received written responses after the initial roundtables on SCM had been held. The TEG have, since then, reviewed these written responses and will be making sure they too are properly reflected in a summary document which will be published on GOV.UK.

Answering body: Cabinet Office

The Scheme has been designed to minimise as far as possible the burden on those applying, and as set out in the Infected Blood Compensation Scheme Regulations 2024, eligibility for the Scheme will be determined based on the balance of probabilities. The Infected Blood Compensation Authority will provide assistance to those who believe their medical records have been lost or destroyed.

In addition to this, on 3 July 2025, the Permanent Secretary of the Cabinet Office wrote to the Chairs of the PAC and PACAC Committees to set out the measures being taken to prioritise faster compensation payments, and one of these measures is to use the powers in the Victims and Prisoners Act to get records from the Infected Blood Inquiry, and using testimony to contribute to the assessment of proof of infection.

Answering body: Cabinet Office

As stated in my previous answer to Question 71230, to provide additional background information on each booking would incur disproportionate costs as this information is not centrally held.

Answering body: Cabinet Office

The Infected Blood Inquiry 2024-25 financial report was published on 6 November, the same day that the audited figures were approved for publication. The report can be found here: https://www.infectedbloodinquiry.org.uk/about/financial-reports

Answering body: Cabinet Office

The Chair of the Infected Blood Inquiry has been paid at the level of a High Court judge, except that he has declined any pension as a result of his work for the Inquiry. The Ministry of Justice publishes the judicial salaries each year. The Chair of the Infected Blood Inquiry is currently receiving one tenth of this salary in recompense for his work.

Answering body: Cabinet Office

The Public Office (Accountability) Bill is currently progressing through parliament. The legislation will include a requirement that all public bodies establish a professional duty of candour for staff set out within a wider code of ethics. This obligation will require public bodies to promote the ethical conduct of their employees. The Government will drive forward implementation with determination and hold public sector organisations accountable. Public Sector leaders will join ministers on a dedicated new implementation board to monitor progress.

Public inquiries are independent of Government and can make recommendations of their choosing. Government takes the recommendations of inquiries very seriously, and determines which recommendations it accepts. To ensure clarity and transparency of progress on the recommendations that Government has accepted, we have established a record on GOV.UK of inquiry recommendations, starting with the Grenfell Tower Inquiry and Infected Blood Inquiry. This will be periodically updated and expanded to capture future inquiry recommendations. This will be an enduring mechanism for monitoring and tracking government implementation of inquiry recommendations. It will allow the public to track the progress of implementation enhancing public trust in Government.

Answering body: Cabinet Office

Public inquiries are independent of Government and can make recommendations of their choosing. Government takes the recommendations of inquiries very seriously, and determines which recommendations it accepts. To ensure clarity and transparency of progress on the recommendations that Government has accepted, we have established a record on GOV.UK of inquiry recommendations, starting with the Grenfell Tower Inquiry and Infected Blood Inquiry. This will be periodically updated and expanded to capture future inquiry recommendations. This will be an enduring mechanism for monitoring and tracking government implementation of inquiry recommendations. It will allow the public to track the progress of implementation enhancing public trust in Government.

Answering body: Cabinet Office

Like all Inquiry Chairs, the Chair of the Infected Blood Inquiry is remunerated for the work he undertakes.

Answering body: Cabinet Office

Published costs for the Infected Blood Inquiry can be found on the inquiry webpage. The latest financial report was published on 27 August 2024. Additionally, the Infected Blood Compensation Authority has published an annual report enclosing a financial statement up to 31 March 2025.

Answering body: Cabinet Office

On 9 July 2025 the Infected Blood Inquiry published its Additional Report on Compensation. The Inquiry made a number of recommendations to the Cabinet Office and to the Infected Blood Compensation Authority (IBCA) to ensure that fair compensation is provided to every person that is eligible without delay.

As of 21 October, IBCA has contacted over 3,614 people to start their compensation claim, and 3,371 have started the claim process. 2,476 people have received an offer, totalling over £1.8 billion, and so far 2,033 people have had their compensation paid with more than £1.35 billion paid in compensation by IBCA. IBCA has now contacted all registered infected people to begin a claim, and the Government expects IBCA to open the service for those who are infected and unregistered, deceased infected and affected this year.

I am pleased that progress is being made, but I acknowledge the calls from the community highlighting the need for faster payment. That is why, on 21 July 2025, I informed the House that the Government would make a further interim payment of £210,000 to the estates of infected persons who were registered with an Infected Blood Support Scheme or predecessor scheme (on or before 17 April 2024) and have sadly passed away.

This is in addition to the interim payment of £100,000 which opened for applications in October 2024, meaning an estate could be eligible for up to £310,000 in interim payments. Since applications opened, over 600 estates have received payment, totalling over £60 million.

Today, I can announce that the process under which estates can apply for a further interim compensation payment has now opened. I hope this payment goes some way in recognising the hurt of those who have been impacted by losing their loved ones due to infected blood and blood products.

These payments will be delivered through the existing Infected Blood Support Schemes. They will be made to the estates of deceased infected persons As with all compensation payments related to infected blood, it will be exempt from income tax, capital gains tax and inheritance tax and disregarded from means tested benefit assessments.

Only the personal representative of the estate is able to make the application. Applicants will need a grant of probate, letters of administration, or a grant of confirmation (specific to Scotland) to evidence entitlement to claim interim compensation on behalf of the estate. To assist the legal process of obtaining this evidence as quickly as possible (for those that do not already have it), applicants can claim back their exact legal costs up to £1,500. The application form is available to download online at gov.uk, together with full guidance on how to apply.

For those estates that have already received £100,000 an expedited application form is available. This requires much less information from the applicant than provided previously. Estate representatives can access this directly by contacting the UK Infected Blood Support Schemes.

I hope this additional interim payment brings some relief to the families impacted by a scandal that is a shameful mark on our national history. Please rest assured that delivering compensation for every person that is eligible remains an utmost priority for this Government.

Answering body: Cabinet Office

On 21st July, I updated the House that the Government would be bringing forward further regulations to respond to the recommendations of the Infected Blood Inquiry’s Additional Report. I also informed the House that to make the proposed changes to the Infected Blood Compensation Scheme would require further technical clinical and legal advice. I can now confirm that this advice will be provided by a new Infected Blood Compensation Scheme Technical Expert Group.

The Technical Expert Group will assist the Government in developing proposals, in response to the Inquiry’s Additional Report, for public consultation. Following that consultation, the Government will be in a position to finalise any changes to the Infected Blood Compensation Scheme, informed by the consultation findings and the Technical Expert Group’s advice.

I have published the Terms of Reference for the Technical Expert Group, including full membership, as well as its work programme. To ensure the necessary changes to the compensation scheme can be implemented with the minimum possible delay to IBCA’s ongoing delivery of compensation, I am appointing all members of the previous Expert Group to the new group. In addition, I am pleased to have personally appointed five further experts to broaden the group’s expertise and ensure any changes to the scheme are thoroughly assessed and validated. The new additional members to the Technical Expert Group are as follows:

Dr Lise Estcourt, Transfusion Medicine specialist

Dr Susie Shapiro, Haematology Specialist

Dr Chloe Beale, Psychological medicine - psychiatrist

Professor Deborah Christie, Psychological medicine - psychologist

Professor John Weinman, Psychological medicine - psychologist

The appointments I have made reflect feedback from infected blood community stakeholders and I thank the community representatives for their valuable input into this process.

While the previous Expert Group, appointed by my predecessor, provided advice which enabled the Government to take critical decisions on the design of the Infected Blood Compensation Scheme, I acknowledge the Inquiry’s and community’s criticisms about the transparency of its work.

After reflecting on the Inquiry’s report, I gave the House an undertaking that transparency will be at the heart of any expert group going forward. Today I published an open letter to Professor Sir Jonathan Montgomery, who I have asked to Chair the new Technical Expert Group, setting out my expectations on how it will operate. This includes an expectation that the group will undertake targeted engagement with the infected blood community on issues raised in the Inquiry’s Additional Report, to inform its work and help it answer the questions set out in its work programme.

Answering body: Department of Health and Social Care

The Government is supportive of the review it inherited into the effectiveness of the statutory duty of candour for health and social care providers. Our aim is to ensure that all providers, including mental health trusts, and their leaders act upon the duty consistently and effectively to improve openness, coupled with effective enforcement by the Care Quality Commission.

The review included a call for evidence, and the Government published its findings on 26 November 2024. These findings are available at the following link:

https://www.gov.uk/government/publications/findings-of-the-call-for-evidence-on-the-statutory-duty-of-candour/findings-of-the-call-for-evidence-on-the-statutory-duty-of-candour

The Government also launched a public consultation on 26 November 2024, on proposals to regulate National Health Service managers. This sought views on making managers, including those in mental health providers, accountable for ensuring that the statutory duty is correctly followed in their organisation. In finalising the review on the statutory duty of candour, we are considering our proposals on candour set out in the Government’s response to the consultation, which was published on 21 July 2024, and other areas including recommendations made by the Infected Blood Inquiry. The consultation response is available at the following link:

https://www.gov.uk/government/consultations/leading-the-nhs-proposals-to-regulate-nhs-managers/outcome/leading-the-nhs-proposals-to-regulate-nhs-managers-consultation-response

Answering body: Cabinet Office

The Cabinet Office’s contract with Calder Conferences Limited to provide Venue Booking Services started in February 2023, under the previous administration.

The below table lists the venues and costs of venues booked by the Cabinet Office through Calder Conferences since 4 July 2024. Of the 223 bookings listed, 198 were commissioned under previous guidance regarding the booking of external venues, and 25 were commissioned following updated guidance issued by this government on 4 April 2025.

To provide further background information on each booking would incur disproportionate costs, but these have included events such as Civil Service Live 2025 and hearings for the Infected Blood Inquiry. These two events account for just over £587,000 of the costs of external venue hires via Calder since 4 April 2025.

This government’s updated guidance on restrictions to booking external venues, issued on 4 April 2025, makes clear that external venues for away days are only to be used when space in government buildings or zero cost venues is unavailable. When it is absolutely necessary to procure an external venue, departments must do so through established procurement routes. Any expenditure related to away days must demonstrate value for money and adhere to reasonable cost expectations.

Bookings commissioned between 04 July 2024 and 4 April 2025

<tbody>

Start Date

End Date

Venue Name

Venue Address

Value (excl. VAT)

10/07/2024

11/07/2024

Sandy Park Conference and Banqueting Centre Exeter

Exeter EX2

£7,332.63

16/7/2024

16/7/2024

The Great Victoria Hotel

Bradford BD1

£291.67

17/7/2024

17/7/2024

University of Westminster - Marylebone

London NW1

£192.00

22/7/2024

22/7/2024

Leonardo Hotel Manchester Central - Formerly Jurys Inn Manchester

Manchester M1 5

£284.25

30/07/2024

30/07/2024

The Wesley Hotel & Conference Venue

London NW1

£825.00

28/08/2024

28/08/2024

Radisson Blu Hotel Birmingham

Birmingham B1 1

£345.83

29/08/2024

29/08/2024

Townhouse Hotel Manchester

Manchester M1 6

£938.34

09/09/2024

10/09/2024

Park Plaza Leeds

Leeds LS1

£2,250.00

10/09/2024

10/09/2024

Park Plaza County Hall London

London SE1

£1,675.00

11/09/2024

11/09/2024

The Westminster London, Curio Collection by Hilton

London SW1P

£2,206.00

13/09/2024

13/09/2024

Chamber Space

Manchester M3 3

£615.00

17/09/2024

17/09/2024

Mary Ward House

London WC1H

£2,445.00

17/09/2024

17/09/2024

Radisson Blu Hotel Glasgow

Glasgow G2 8

£250.00

18/09/2024

18/09/2024

Clayton Hotel Glasgow City Centre

Glasgow G1 4

£3,750.00

18/09/2024

18/09/2024

One Great George Street

London SW1P

£3,453.55

18/09/2024

18/09/2024

Royal Station Hotel

Newcastle-upon-Tyne NE1

£2,670.67

18/09/2024

18/09/2024

The Principal York

York YO24

£747.91

19/09/2024

19/09/2024

Clayton Hotel Belfast

Belfast BT2

£166.67

21/09/2024

21/09/2024

Hotel Afa

Pristina 1000 Kosovo

£627.70

24/09/2024

24/09/2024

Hotel Afa

Pristina 1000 Kosovo

£631.97

24/09/2024

24/09/2024

Macdonald Burlington Hotel

Birmingham B2 4

£2,437.50

24/09/2024

24/09/2024

The Chesterfield Mayfair Hotel, Red Carnation Hotels

London W1J

£630.00

24/09/2024

24/09/2024

Wellington Hotel by Blue Orchid Hospitality

London SW1P

£396.75

25/09/2024

25/09/2024

Crowne Plaza Birmingham City Centre

Birmingham B1 1

£487.50

26/09/2024

26/09/2024

The Kia Oval

London SE11

£23,147.50

29/09/2024

02/10/2024

Modern City Hotel

Tamale C5Q3

£5,513.02

30/09/2024

30/09/2024

Broadway House

London SW1H

£2,250.00

01/10/2024

01/10/2024

The Mermaid London

London EC4V

£56,899.00

02/10/2024

04/10/2024

Leonardo Royal Hotel Birmingham

Birmingham B1 2

£1,233.55

06/10/2024

06/10/2024

The Royal Senchi

Akosombo 0 Ghana

£14,679.38

10/10/2024

10/10/2024

The Royal Horseguards and One Whitehall Place

London SW1A

£16,365.00

15/10/2024

16/10/2024

Hilton Podgorica Crna Gora

Podgorica 8100 Montenegro

£616.32

17/10/2024

17/10/2024

Manchester Marriott Hotel Piccadilly

Manchester M1 2

£11,673.17

17/10/2024

18/10/2024

Wilton Park Conference Centre

Steyning BN44

£13,815.35

22/10/2024

22/10/2024

Hilton Podgorica Crna Gora

Podgorica 8100 Montenegro

£670.46

23/10/2024

23/10/2024

Park Plaza County Hall London

London SE1

£2,158.00

29/10/2024

31/10/2024

Bianca Resort & Spa

Kolasin 8121 Montenegro

£4,500.25

30/10/2024

30/10/2024

Novotel Bristol Centre

Bristol BS1

£770.83

06/11/2024

06/11/2024

&Meetings - Birmingham

Birmingham B2 5

£90.00

06/11/2024

08/11/2024

Hilton Leeds City

Leeds LS1

£2,232.96

06/11/2024

06/11/2024

The Wesley Hotel & Conference Venue

London NW1

£3,400.00

12/11/2024

13/11/2024

Voco Leicester

Leicester LE2

£2,100.00

13/11/2024

14/11/2024

Central Hall Westminster

London SW1H

£1,176.00

14/11/2024

14/11/2024

QEII Centre

London SW1P

£26,253.03

14/11/2024

14/11/2024

The Birmingham and Midland Institute

Birmingham B3 3

£2,210.00

15/11/2024

15/11/2024

Fermanagh House

Enniskillen BT74

£209.00

15/11/2024

15/11/2024

Imperial War Museum

London SE1

£1,380.00

19/11/2024

19/11/2024

Radisson Blu Hotel Glasgow

Glasgow G2 8

£1,099.99

20/11/2024

21/11/2024

etc.venues Manchester

Manchester M1 3

£2,480.00

26/11/2024

26/11/2024

Hilton York

York YO1

£350.76

28/11/2024

28/11/2024

Manchester Central

Manchester M2 3

£26,670.05

03/12/2024

03/12/2024

etc.venues County Hall

London SE1

£1,270.00

03/12/2024

08/12/2024

Hilton Podgorica Crna Gora

Podgorica 8100 Montenegro

£4,413.46

04/12/2024

04/12/2024

Asia House

London W1G

£3,403.75

04/12/2024

04/12/2024

etc.venues Manchester

Manchester M1 3

£900.00

04/12/2024

06/12/2024

Mercure Liverpool Atlantic Tower Hotel

Liverpool L3 9

£2,700.00

04/12/2024

04/12/2024

The Studio Birmingham

Birmingham B2 5

£1,760.50

04/12/2024

06/12/2024

The Birmingham Conference & Events Centre at the Holiday Inn Birmingham City Centre

Birmingham B5 4

£3,088.33

05/12/2024

05/12/2024

Mercure Cardiff Holland House Hotel & Spa

Cardiff CF24

£250.00

5/12/2024

5/12/2024

The Royal Society

London SW1Y

£2,745.00

05/12/2024

06/12/2024

Avari Hotel Lahore

Punjab Pakistan

£717.72

09/12/2024

10/12/2024

Dunsilly Hotel

Antrim BT41

£2,225.84

09/12/2024

09/12/2024

Pendulum Hotel & Manchester Conference Centre

Manchester M1 3

£2,383.33

10/12/2024

11/12/2024

Glasgow Training Rooms

Glasgow G3 8

£1,030.00

10/12/2024

12/12/2024

Copthorne Tara Hotel London Kensington

London W8 5

£1,204.17

10/12/2024

12/12/2024

Grange Clarendon Hotel

London WC1B

£4,550.00

11/12/2024

11/12/2024

IET Birmingham: Austin Court

Birmingham B1 2

£3,080.00

11/12/2024

11/12/2024

Leonardo Royal Hotel London Tower Bridge

London E1 8

£1,725.00

11/12/2024

11/12/2024

Prince Philip House

London SW1Y

£921.60

11/12/2024

11/12/2024

Royal Hospital Chelsea

London SW3

£197.00

11/12/2024

11/12/2024

The Royal Horseguards and One Whitehall Place

London SW1A

£7,795.00

11/12/2024

11/12/2024

Townhouse Hotel Manchester

Manchester M1 6

£272.08

12/12/2024

13/12/2024

Leonardo Royal Hotel Birmingham

Birmingham B1 2

£4,715.01

12/12/2024

12/12/2024

The Studio Birmingham

Birmingham B2 5

£1,054.80

13/12/2024

13/12/2024

Leonardo Royal Hotel London Tower Bridge

London E1 8

£1,346.14

18/12/2024

18/12/2024

Mercure Bristol Grand Hotel

Bristol BS1

£3,332.48

14/01/2025

16/01/2025

CCT Venues-Smithfield

Smithfield EC1A

£10,327.50

14/01/2025

14/01/2025

etc.venues Manchester

Manchester M1 3

£1,410.00

14/01/2025

14/01/2025

IET Birmingham: Austin Court

Birmingham B1 2

£740.00

14/01/2025

14/01/2025

Marlin Waterloo

London SE1

£445.00

15/01/2025

15/01/2025

Church House Westminster

London SW1P

£8,461.50

15/01/2025

15/01/2025

Churchill War Rooms

London SW1A

£6,651.15

20/01/2025

22/01/2025

Hilton Podgorica Crna Gora

Podgorica 8100 Montenegro

£768.90

20/01/2025

21/01/2025

Royal Station Hotel

Newcastle-upon-Tyne NE1

£1,702.07

20/01/2025

21/01/2025

The Hawkhills

Easingwold YO61

£7,134.17

21/01/2025

21/01/2025

etc.venues Manchester

Manchester M1 3

£2,750.00

21/01/2025

21/01/2025

Park Inn by Radisson Aberdeen

Aberdeen AB11

£270.83

22/01/2025

22/01/2025

The Met Hotel, Leeds

Leeds LS1

£4,691.66

23/01/2025

23/01/2025

Church House Westminster

London SW1P

£15,370.00

23/01/2025

23/01/2025

Manchester Art Gallery

Manchester M2 3

£2,496.40

27/01/2025

30/01/2025

Radisson Blu Hotel, Edinburgh City Centre

Edinburgh EH1

£12,012.51

27/01/2025

29/01/2025

Stanbrook Abbey Hotel

Worcester WR2

£3,113.72

28/01/2025

28/01/2025

Design Museum

London W8 6

£10,000.00

28/01/2025

28/01/2025

DoubleTree by Hilton London Angel Kings Cross

London N1 9

£2,245.83

29/1/2025

29/1/2025

Design Museum

London W8 6

£42,000.00

30/01/2025

30/01/2025

Broadway House

London SW1H

£679.60

30/01/2025

30/01/2025

Crowne Plaza Birmingham City Centre

Birmingham B1 1

£577.20

30/01/2025

30/01/2025

The Union Jack Club

London SE1

£462.71

04/02/2025

04/02/2025

Broadway House

London SW1H

£1,089.00

05/02/2025

05/02/2025

Central Hall Westminster

London SW1H

£7,467.58

05/02/2025

05/02/2025

The Royal Society

London SW1Y

£30,413.25

06/02/2025

06/02/2025

Marlin Waterloo

London SE1

£445.00

06/02/2025

06/02/2025

Townhouse Hotel Manchester

Manchester M1 6

£428.33

10/02/2025

10/02/2025

Broadway House

London SW1H

£823.50

10/02/2025

10/02/2025

Broadway House

London SW1H

£1,213.00

11/02/2025

13/02/2025

Novotel Manchester Centre

Manchester M1 4

£416.66

11/02/2025

11/02/2025

Townhouse Hotel Manchester

Manchester M1 6

£385.42

12/02/2025

14/02/2025

Crowne Plaza Bandung

Jakarta 4011 Indonesia

£14,580.90

12/02/2025

12/02/2025

Hilton Podgorica Crna Gora

Podgorica 8100 Montenegro

£1,891.50

12/02/2025

12/02/2025

Royal National Hotel

London WC1H

£6,916.67

12/02/2025

12/02/2025

The Wesley Hotel & Conference Venue

London NW1

£3,141.67

13/02/2025

13/02/2025

The Kia Oval

London SE11

£24,713.76

14/02/2025

14/02/2025

One Birdcage Walk

London SW1H

£2,184.60

18/02/2025

18/02/2025

Holiday Inn London Bloomsbury

London WC1N

£9,087.50

18/02/2025

18/02/2025

Hotel Splendid Conference and Spa Resort

Becici 8531 Montenegro

£1,078.32

18/02/2025

19/02/2025

Mercure Manchester Piccadilly Hotel

Manchester M1 4

£416.67

19/02/2025

19/02/2025

Broadway House

London SW1H

£2,400.50

19/02/2025

21/02/2025

Park Plaza Leeds

Leeds LS1

£12,974.16

20/02/2025

21/02/2025

Hilton Podgorica Crna Gora

Podgorica 8100 Montenegro

£2,662.51

24/02/2025

24/02/2025

Clayton Hotel Birmingham & Conference Centre

Birmingham B5 5

£650.00

24/02/2025

26/02/2025

Mandarin Oriental, Jakarta

Jakarta 1031 Indonesia

£7,264.87

25/02/2025

25/02/2025

Thistle London Marble Arch

London W1H

£17,474.99

26/02/2025

26/02/2025

Ambassadors Bloomsbury Hotel

London WC1H

£3,932.50

27/02/2025

28/02/2025

The Royal Horseguards and One Whitehall Place

London SW1A

£8,481.67

04/03/2025

04/03/2025

Broadway House

London SW1H

£2,400.50

04/03/2025

04/03/2025

Broadway House

London SW1H

£2,196.00

04/03/2025

04/03/2025

Hilton York

York YO1

£733.33

04/03/2025

04/03/2025

Lysses House Hotel

Fareham PO16

£250.00

04/03/2025

06/03/2025

Manchester Marriott Hotel Piccadilly

Manchester M1 2

£13,509.75

05/03/2025

05/03/2025

Mary Ward House

London WC1H

£8,163.80

05/03/2025

05/03/2025

National Museums Liverpool

Liverpool L2 2

£30,384.60

11/03/2025

11/03/2025

Bletchley Park

Milton Keynes MK3

£22,084.00

11/03/2025

11/03/2025

Churchill War Rooms

London SW1A

£2,190.00

12/03/2025

12/03/2025

etc.venues County Hall

London SE1

£550.00

12/03/2025

13/03/2025

The Milner York, formerly The Principal

York YO24

£8,615.01

17/03/2025

17/03/2025

Admirable Crichton

London SE5

£2,139.46

18/03/2025

20/03/2025

CCT Venues-Smithfield

Smithfield EC1A

£10,042.00

18/03/2025

21/03/2025

Novotel Leeds Centre

Leeds LS1

£4,646.66

20/03/2025

20/03/2025

8 Northumberland Avenue

London WC2N

£21,700.00

20/03/2025

20/03/2025

Leonardo Royal Hotel Birmingham

Birmingham B1 2

£5,100.00

20/03/2025

20/03/2025

Marlin Waterloo

London SE1

£495.00

20/03/2025

20/03/2025

Radisson Blu Hotel Liverpool

Liverpool L3 9

£725.00

24/03/2025

26/03/2025

Nottingham Venues - The Jubilee Hotel & Conferences

Nottingham NG7

£23,581.97

24/03/2025

24/03/2025

The Royal Society

London SW1Y

£6,653.00

25/03/2025

26/03/2025

Broadway House

London SW1H

£2,500.00

25/03/2025

25/03/2025

etc.venues Manchester

Manchester M1 3

£2,785.00

25/03/2025

25/03/2025

Novotel London Waterloo

London SE1

£678.33

26/03/2025

26/03/2025

Amplitude Event Solutions Ltd

Shipley BD18

£7,085.00

26/03/2025

26/03/2025

Broadway House

London SW1H

£2,110.00

26/03/2025

26/03/2025

Civil Service Club

London SW1A

£1,400.34

26/03/2025

26/03/2025

Clayton Hotel Manchester City Centre

Manchester M1 3

£3,404.16

26/03/2025

28/03/2025

Hyatt Place & Hyatt House Leeds

Leeds LS1

£3,741.66

27/03/2025

27/03/2025

Delta Hotels by Marriott Liverpool City Centre.

Liverpool L1 1

£583.33

27/03/2025

27/03/2025

Malmaison York

York YO90

£4,570.84

31/03/2025

04/04/2025

Clayton Hotel Glasgow City Centre

Glasgow G1 4

£2,666.66

31/03/2025

31/03/2025

Marlin Waterloo

London SE1

£755.00

01/04/2025

01/04/2025

Body and Soul Charity

London EC1R

£350.00

02/04/2025

02/04/2025

Central Hall Westminster

London SW1H

£12,858.50

02/04/2025

03/04/2025

The Midland Hotel - Manchester

Manchester M60

£1,500.00

03/04/2025

03/04/2025

10-11 Carlton House Terrace

London SW1Y

£1,450.83

03/04/2025

03/04/2025

Broadway House

London SW1H

£1,620.00

03/04/2025

03/04/2025

MGi London Media & Events

London W1B

£2,050.00

03/04/2025

05/04/2025

Wilton Park Conference Centre

Steyning BN44

£16,434.70

22/04/2025

23/04/2025

Crowne Plaza Newcastle - Stephenson Quarter

Newcastle-upon-Tyne NE1

£1,447.49

23/04/2025

24/04/2025

Conference Aston Hotel Birmingham

Birmingham B4 7

£10,651.41

29/04/2025

30/04/2025

Clayton Hotel Manchester City Centre

Manchester M1 3

£3,946.70

29/04/2025

29/04/2025

Radisson Hotel York

York YO1

£4,179.17

30/04/2025

30/04/2025

Cardiff Castle

Cardiff CF10

£4,550.00

30/04/2025

30/04/2025

Park Plaza County Hall London

London SE1

£2,194.00

30/04/2025

30/04/2025

The Birmingham Conference & Events Centre at the Holiday Inn Birmingham City Centre

Birmingham B5 4

£4,345.00

01/05/2025

01/05/2025

QEII Centre

London SW1P

£29,296.45

01/05/2025

01/05/2025

The Alan

Manchester M1 4

£665.00

07/05/2025

07/05/2025

etc.venues Manchester

Manchester M1 3

£2,785.00

09/05/2025

09/05/2025

De Vere Grand Connaught Rooms

London WC2B

£7,206.20

12/05/2025

16/05/2025

Clayton Hotel Leeds

Leeds LS11

£5,791.67

13/05/2025

15/05/2025

CCT Venues-Smithfield

Smithfield EC1A

£10,042.00

13/05/2025

14/05/2025

Radisson Blu Hotel, Sheffield

Sheffield S1 2

£6,811.67

13/05/2025

13/05/2025

RSA House

London WC2N

£6,690.00

14/05/2025

14/05/2025

Novotel Manchester Centre

Manchester M1 4

£1,866.67

19/05/2025

22/05/2025

The Met Hotel, Leeds

Leeds LS1

£8,725.00

20/05/2025

20/05/2025

etc.venues Monument

London EC3M

£10,445.00

21/05/2025

21/05/2025

De Vere Grand Connaught Rooms

London WC2B

£6,678.33

09/06/2025

14/06/2025

Radisson Blu Hotel, Edinburgh City Centre

Edinburgh EH1

£12,387.50

17/06/2025

19/06/2025

Venue Cranfield - Hotel and Conference Centre

Milton Keynes MK43

£4,097.50

23/06/2025

23/06/2025

One Great George Street

London SW1P

£2,702.00

24/06/2025

25/06/2025

Utilita Arena Cardiff

Cardiff CF10

£8,000.00

25/06/2025

27/06/2025

Conference Aston Hotel Birmingham

Birmingham B4 7

£11,428.31

30/06/2025

03/07/2025

The Westminster London, Curio Collection by Hilton

London SW1P

£6,225.00

01/07/2025

03/07/2025

CCT Venues-Smithfield

Smithfield EC1A

£10,292.50

01/07/2025

02/07/2025

Northumbria University

Newcastle-upon-Tyne NE2

£19,590.00

03/07/2025

03/07/2025

Townhouse Hotel Manchester

Manchester M1 6

£1,225.00

04/07/2025

04/07/2025

Royal National Hotel

London WC1H

£18,280.81

07/07/2025

09/07/2025

Excel London

London E16

£123,843.72

14/07/2025

15/07/2025

ACC Liverpool

Liverpool L3 4

£86,770.00

15/07/2025

17/07/2025

The Hawkhills

Easingwold YO61

£3,420.00

16/07/2025

17/07/2025

Sandy Park Conference and Banqueting Centre Exeter

Exeter EX2

£22,846.67

09/09/2025

09/09/2025

RSA House

London WC2N

£15,323.25

17/09/2025

17/09/2025

Marlin Waterloo

London SE1

£653.33

TOTAL

£1,364,221.74

</tbody>

Bookings commissioned after 4 April 2025

<tbody>

06/05/2025

09/05/2025

Church House Westminster

London SW1P

£163,505.00

08/05/2025

08/05/2025

Glasgow Argyle Hotel, Signature Collection by Best Western

Glasgow G3 8

£395.83

12/05/2025

12/05/2025

Broadway House

London SW1H

£1,215.00

14/05/2025

14/05/2025

110 Rochester Row

London SW1P

£4,524.50

16/05/2025

16/05/2025

Holiday Inn Cardiff City Centre

Cardiff CF10

£867.51

21/05/2025

22/05/2025

Dynamic Earth

Edinburgh EH8

£18,336.40

21/05/2025

22/05/2025

Manchester Central

Manchester M2 3

£81,010.43

29/05/2025

29/05/2025

The Old Ship Hotel

Brighton BN1

£494.67

04/06/2025

04/06/2025

RSA House

London WC2N

£8,654.00

09/06/2025

10/06/2025

Scottish Event Campus (SEC)

Glasgow G3 8

£53,743.00

11/06/2025

12/06/2025

ICC Belfast - Waterfront Hall

Belfast BT1

£31,499.11

11/06/2025

11/06/2025

Mercure Glasgow City Hotel

Glasgow G1 1

£923.33

16/06/2025

17/06/2025

Crowne Plaza Newcastle-Stephenson Quarter

Newcastle-upon-Tyne NE1

£1,346.17

24/06/2025

24/06/2025

Leonardo Hotel Manchester Central

Manchester M1 5

£127.50

01/07/2025

03/07/2025

Venue Cranfield - Hotel and Conference Centre

Milton Keynes MK43

£2,134.13

07/07/2025

10/07/2025

Courtyard by Marriott Oxford City Centre

Oxford OX1

£28,220.00

09/07/2025

10/07/2025

Linton Lodge Hotel, BW Signature Collection

Oxford OX2

£687.50

09/07/2025

09/07/2025

Westminster Chapel

London SW1E

£23,565.66

16/07/2025

16/07/2025

Leonardo Royal Hotel Birmingham

Birmingham B1 2

£812.50

16/07/2025

16/07/2025

Leonardo Royal Hotel London Tower Bridge

London E1 8

£29,226.67

22/07/2025

22/07/2025

Mercure Manchester Piccadilly Hotel

Manchester M1 4

£208.33

28/07/2025

28/07/2025

Radisson Blu Hotel Cardiff

Cardiff CF10

£250.00

15/09/2025

16/09/2025

Manchester Hall

Manchester M3 3

£10,475.00

07/10/2025

08/10/2025

Wilton Park Conference Centre

Steyning BN44

£59,260.00

13/11/2025

13/11/2025

St Mary's Marylebone

London W1H

£7,000.00

TOTAL

£791,679.26

</tbody>